166 related articles for article (PubMed ID: 21821012)
1. PARP1 inhibitors attenuate AKT phosphorylation via the upregulation of PHLPP1.
Wang S; Wang H; Davis BC; Liang J; Cui R; Chen SJ; Xu ZX
Biochem Biophys Res Commun; 2011 Aug; 412(2):379-84. PubMed ID: 21821012
[TBL] [Abstract][Full Text] [Related]
2. MAPK4 deletion enhances radiation effects and triggers synergistic lethality with simultaneous PARP1 inhibition in cervical cancer.
Tian S; Lou L; Tian M; Lu G; Tian J; Chen X
J Exp Clin Cancer Res; 2020 Jul; 39(1):143. PubMed ID: 32711558
[TBL] [Abstract][Full Text] [Related]
3. PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1.
Pinton G; Manente AG; Murer B; De Marino E; Mutti L; Moro L
J Cell Mol Med; 2013 Feb; 17(2):233-41. PubMed ID: 23301673
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of PARP1 by small interfering RNA enhances docetaxel activity against human prostate cancer PC3 cells.
Wu W; Kong Z; Duan X; Zhu H; Li S; Zeng S; Liang Y; Iliakis G; Gui Z; Yang D
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):127-32. PubMed ID: 24239883
[TBL] [Abstract][Full Text] [Related]
5. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells.
Zhiqiang Z; Qinghui Y; Yongqiang Z; Jian Z; Xin Z; Haiying M; Yuepeng G
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1231-8. PubMed ID: 22426999
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling
Chern Y; Zhang P; Ju H; Tai IT
Cancer Biol Med; 2020 May; 17(2):343-356. PubMed ID: 32587773
[No Abstract] [Full Text] [Related]
7. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
8. Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression.
Huang YS; Chang CC; Lee SS; Jou YS; Shih HM
Oncotarget; 2016 Jul; 7(28):43256-43266. PubMed ID: 27248326
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) polymerase 1 is indispensable for transforming growth factor-β Induced Smad3 activation in vascular smooth muscle cell.
Huang D; Wang Y; Wang L; Zhang F; Deng S; Wang R; Zhang Y; Huang K
PLoS One; 2011; 6(10):e27123. PubMed ID: 22073128
[TBL] [Abstract][Full Text] [Related]
10. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast.
Perkins E; Sun D; Nguyen A; Tulac S; Francesco M; Tavana H; Nguyen H; Tugendreich S; Barthmaier P; Couto J; Yeh E; Thode S; Jarnagin K; Jain A; Morgans D; Melese T
Cancer Res; 2001 May; 61(10):4175-83. PubMed ID: 11358842
[TBL] [Abstract][Full Text] [Related]
11. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.
Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608
[TBL] [Abstract][Full Text] [Related]
12. Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors.
Du Y; Yamaguchi H; Wei Y; Hsu JL; Wang HL; Hsu YH; Lin WC; Yu WH; Leonard PG; Lee GR; Chen MK; Nakai K; Hsu MC; Chen CT; Sun Y; Wu Y; Chang WC; Huang WC; Liu CL; Chang YC; Chen CH; Park M; Jones P; Hortobagyi GN; Hung MC
Nat Med; 2016 Feb; 22(2):194-201. PubMed ID: 26779812
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic suppression of PHLPP1 in human melanoma.
Dong L; Jin L; Tseng HY; Wang CY; Wilmott JS; Yosufi B; Yan XG; Jiang CC; Scolyer RA; Zhang XD; Guo ST
Oncogene; 2014 Sep; 33(39):4756-66. PubMed ID: 24121273
[TBL] [Abstract][Full Text] [Related]
14. Scribble-mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt.
Li X; Yang H; Liu J; Schmidt MD; Gao T
EMBO Rep; 2011 Jun; 12(8):818-24. PubMed ID: 21701506
[TBL] [Abstract][Full Text] [Related]
15. Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells.
Chuang HC; Kapuriya N; Kulp SK; Chen CS; Shapiro CL
Breast Cancer Res Treat; 2012 Jul; 134(2):649-59. PubMed ID: 22678161
[TBL] [Abstract][Full Text] [Related]
16. USP46 Inhibits Cell Proliferation in Lung Cancer through PHLPP1/AKT Pathway.
Wang W; Chen M; Xu H; Lv D; Zhou S; Yang H
Biomed Res Int; 2020; 2020():2509529. PubMed ID: 33029497
[TBL] [Abstract][Full Text] [Related]
17. beta-TrCP-mediated ubiquitination and degradation of PHLPP1 are negatively regulated by Akt.
Li X; Liu J; Gao T
Mol Cell Biol; 2009 Dec; 29(23):6192-205. PubMed ID: 19797085
[TBL] [Abstract][Full Text] [Related]
18. Exploitation of the ability of γ-tocopherol to facilitate membrane co-localization of Akt and PHLPP1 to develop PHLPP1-targeted Akt inhibitors.
Yan R; Chuang HC; Kapuriya N; Chou CC; Lai PT; Chang HW; Yang CN; Kulp SK; Chen CS
J Med Chem; 2015 Mar; 58(5):2290-8. PubMed ID: 25689347
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Salmonella-induced IL-6 production in Caco-2 cells by PJ-34, PARP-1 inhibitor: involvement of PI3K, p38 MAPK, ERK, JNK, and NF-kappaB.
Huang FC
Mediators Inflamm; 2009; 2009():103890. PubMed ID: 20204057
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E facilitates the inactivation of the kinase Akt by the phosphatase PHLPP1.
Huang PH; Chuang HC; Chou CC; Wang H; Lee SL; Yang HC; Chiu HC; Kapuriya N; Wang D; Kulp SK; Chen CS
Sci Signal; 2013 Mar; 6(267):ra19. PubMed ID: 23512990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
